Plasma-derived cfDNA to reveal potential biomarkers of response prediction and monitoring in non-small cell lung cancer (NSCLC) patients on immunotherapy.

被引：0
|
作者：
Vallnia, Francesco
Assayag, Karen
Ulz, Peter
Drake, Adam
Warsinske, Hayley
St John, John
Putcha, Girish
Cabel, Luc
Beaucaire-Danel, Sophie
Girard, Nicolas
Bidard, francois-Clement
机构：
[1] Freenome, San Francisco, CA USA
[2] Inst Curie, Paris, France
[3] Inst Curie, Dept Oncol, Paris, France
[4] Inst Curie, Inst Thorax Curie Montsouris, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9588
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an update
    Blons, Helene
    Garinet, Simon
    Laurent-Puig, Pierre
    Oudart, Jean-Baptiste
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S25 - S36
  • [42] The effect of sex and BMI on outcomes in patients with metastatic non-small cell lung cancer treated with immunotherapy.
    Jin, Jingxiao
    Visina, Jacqueline
    Burns, Timothy F.
    Diergaarde, Brenda
    Stabile, Laura P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Immune-Checkpoint Inhibitors: Biomarkers to Predict Response to Immunotherapy in Non-small Cell Lung Cancer Patients
    Tostes, Senhorita Katiane
    Sorroche, Bruna Pereira
    Rodrigues, Nathalia de Carvalho
    Dias, Tauana Christina
    Lima, Joyce Alessandra
    Ferreira da Silva, Flavio Augusto
    Martins de Marchi, Pedro Rafael
    Pinheiro, Celine Marques
    Leal, Leticia Ferro
    Rebolho Batista Arantes, Lidia Maria
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S26 - S26
  • [44] Radiomic biomarkers from chest computed tomography are assistive in immunotherapy response prediction for non-small cell lung cancer
    Schroeder, Kimberly E.
    Acharya, Luna
    Mani, Hariharasudan
    Furqan, Muhammad
    Sieren, Jessica C.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (05) : 1023 - +
  • [45] Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)
    Corral de la Fuente, E.
    Barquin Garcia, A.
    Saavedra Serrano, C.
    Olmedo Garcia, M. E.
    Martin Huertas, R.
    Serrano Domingo, J. J.
    Albarr Anartahona, V.
    Gomez Rueda, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis
    Paradas, Javier Ramos
    Gomez-Sanchez, David
    Rosado, Aranzazu
    Ferrer, Irene
    Carrizo, Nuria
    Enguita, Ana B.
    Munoz, Maria T.
    Paz-Ares, Luis
    Garrido-Martin, Eva M.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] Potential biomarkers for immunotherapy in non-small-cell lung cancer
    Wang, Xing
    Qiao, Ziyun
    Aramini, Beatrice
    Lin, Dong
    Li, Xiaolong
    Fan, Jiang
    CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 661 - 675
  • [48] Potential biomarkers for immunotherapy in non-small-cell lung cancer
    Xing Wang
    Ziyun Qiao
    Beatrice Aramini
    Dong Lin
    Xiaolong Li
    Jiang Fan
    Cancer and Metastasis Reviews, 2023, 42 : 661 - 675
  • [49] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    LUNG CANCER, 2006, 52 : S19 - S19
  • [50] Immunotherapy causing pneumonitis in a patient with non-small cell lung cancer (NSCLC)
    Li, Rui
    Lee, Gina
    El-Sherief, Ahmed
    BMJ CASE REPORTS, 2019, 12 (03)
12345